The US Securities and Exchange Commission (SEC) is exploring changes that could reshape the landscape for foreign companies listed in New York, potentially delivering a significant boost to the London
All posts tagged in Arm Holdings
3Articles
In a significant move strengthening its technological capabilities, AstraZeneca has appointed Arm Holdings Chief Executive Rene Haas to its board as a non-executive director, effective from next month. The appointment
The sale of British chip designer Arm Holdings represents a significant strategic misstep that may have discouraged other technology firms from choosing London as their listing destination, according to prominent
